Results 111 to 120 of about 2,223 (120)

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

New England Journal of Medicine, 2016
Jochen Seufert, Mark Warren, Ildiko Lingvay   +2 more
exaly  

Targeting hepatic glucose metabolism in the treatment of type 2 diabetes

Nature Reviews Drug Discovery, 2016
Pere B. Puigserver, Kfir Sharabi, Clint D J Tavares   +2 more
exaly  

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

New England Journal of Medicine, 2019
Carol Pollock, Rajiv Agarwal, Bernard Zinman   +2 more
exaly  

Managing diabetes with nanomedicine: challenges and opportunities

Nature Reviews Drug Discovery, 2014
Daniel G Anderson, Kathryn A Whitehead, Benjamin C Tang   +2 more
exaly  

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

New England Journal of Medicine, 2019
Nikolaus Marx, Eri T Kato, Marc S Sabatine   +2 more
exaly  

Prevalence of Diabetes among Men and Women in China

New England Journal of Medicine, 2010
Linong Ji, Chunlan Zhang, Li Chen
exaly  

Androgen Deprivation Raises Risk of Diabetes, Heart Disease

Ca-A Cancer Journal for Clinicians, 2007
exaly  

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

New England Journal of Medicine, 2002
John M. Lachin, Elizabeth Arquin Walker
exaly  

Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction

New England Journal of Medicine, 1998
Markku Laakso, Seppo Lehto, Kalevi Pyörälä   +2 more
exaly  

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

New England Journal of Medicine, 2016
Bernard Zinman, Kirstine Brown-Frandsen, Johannes F E Mann   +2 more
exaly